Get started
Author

Tomonori Kobayakawa

Observed names: Kobayakawa, Tomonori, T. Kobayakawa, 小早川 知範, 小早川, 知範, 小早川知範, 知範 小早川, 裕亘 小杉山
ORCID: 0009-0002-6814-9920
Observed ORCID: 0009-0002-6814-9920
OpenAlex ID: A5028968443
Denosumab versus romosozumab for postmenopausal osteoporosis treatment
2021 · Tomonori Kobayakawa, Akiko Miyazaki, et al. · Scientific Reports · 105
PDF
＜Editors' Choice＞ Ultrasound measurement of thigh muscle thickness for assessment of sarcopenia.
2018 · Tetsuro Hida, Kei Ando, et al. · PubMed Central · 79
PDF
Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study
2021 · Tomonori Kobayakawa, Takako Suzuki, et al. · Bone Reports · 56
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration
2022 · Tomonori Kobayakawa, Akiko Miyazaki, et al. · Modern Rheumatology · 36
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
2020 · Nobunori Takahashi, Shuji Asai, et al. · Scientific Reports · 35
PDF
Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study
2022 · Tomonori Kobayakawa, Akiko Miyazaki, et al. · Bone · 30
PDF
Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate
2014 · Tomonori Kobayakawa, Toshihisa Kojima, et al. · Modern Rheumatology · 19
Therapy with transitions from one bone-forming agent to another: a retrospective cohort study on teriparatide and romosozumab
2024 · Tomonori Kobayakawa, Yasuhide Kanayama, et al. · JBMR Plus · 16
Inhibition of CD44 intracellular domain production suppresses bovine articular chondrocyte de-differentiation induced by excessive mechanical stress loading
2019 · Yasumori Sobue, Nobunori Takahashi, et al. · Scientific Reports · 16
PDF
Mechanical stress loading induces CD44 cleavage in human chondrocytic HCS-2/8 cells
2016 · Tomonori Kobayakawa, Nobunori Takahashi, et al. · Biochemical and Biophysical Research Communications · 16
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study
2025 · Toshitaka Yukishima, Kosuke Ebina, et al. · Osteoporosis International · 15
PDF
Sequential and combination therapy with romosozumab
2025 · Tomonori Kobayakawa · Journal of Bone and Mineral Metabolism · 14
Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis
2021 · Shuji Asai, Nobunori Takahashi, et al. · Clinical Rheumatology · 14
Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis
2022 · Tomonori Kobayakawa, Akiko Miyazaki, et al. · Clinical Nutrition ESPEN · 13
PDF
A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study
2012 · Yuichiro Yabe, Toshihisa Kojima, et al. · Modern Rheumatology · 13
Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study
2025 · Yuki Etani, Takaaki Noguchi, et al. · Bone · 11
PDF
A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis
2025 · Yasumori Sobue, Hironobu Kosugiyama, et al. · Scientific Reports · 10
PDF
Verifying the effectiveness of romosozumab re-administration on bone mineral density
2024 · Tomonori Kobayakawa, Yukio Nakamura · Journal of Bone and Mineral Research · 10
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study
2019 · Shuji Asai, Masatoshi Hayashi, et al. · Modern Rheumatology · 10
PDF
Impact of prior teriparatide treatment on the effectiveness of romosozumab in patients with postmenopausal osteoporosis: A case-control study
2025 · Kosuke Ebina, Tomonori Kobayakawa, et al. · Bone · 8
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab
2020 · Shuji Asai, Nobunori Takahashi, et al. · Joint Bone Spine · 7
A Fatal Case of Relapsing Pneumonia Caused by Legionella pneumophila in a Patient with Rheumatoid Arthritis After Two Injections of Adalimumab
2013 · Masatoshi Hayashi, Hiroshi Kuraishi, et al. · Clinical Medicine Insights Case Reports · 6
Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis
2024 · Shuji Asai, Nobunori Takahashi, et al. · International Journal of Rheumatic Diseases · 5
PDF
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
2024 · Tomonori Kobayakawa, Yasuhide Kanayama, et al. · Scientific Reports · 4
PDF
Age-related response to 12-month romosozumab in treatment-naïve Japanese women aged 55–100 years with primary osteoporosis
2025 · Takaomi Kobayashi, Tomonori Kobayakawa, et al. · Bone · 3
Works count: 63
Citation count: 565
H-index: 13
I10-index: 19
Year
Topic
Type